Description

Glencet Edvans Coated Tablets №28

Ingredients:

Glencet Edvans Coated Tablets №28 contain active ingredient X (XXX mg), inactive ingredients Y, and Z.

Mechanism of Action:

Glencet Edvans Coated Tablets №28 work by inhibiting the production of certain enzymes in the body, leading to a decrease in inflammation and pain associated with the conditions it treats.

Pharmacological Properties:

The medication inhibits specific enzymes, resulting in anti-inflammatory and analgesic effects.

Indications for Use:

Glencet Edvans Coated Tablets №28 are indicated for the treatment of condition A and condition B.

Contraindications:

Glencet Edvans Coated Tablets №28 are contraindicated in patients with a known allergy to any of the ingredients.

Side Effects:

The medication is well-tolerated with minimal side effects.

Usage Instructions:

Glencet Edvans Coated Tablets №28 should be taken orally with water. Do not crush or chew the tablets. The usual dose is XXX mg once daily.

Benefits Compared to Analogues:

Comparative studies have shown that Glencet Edvans Coated Tablets №28 exhibit similar efficacy to other leading medications in its class but with a lower incidence of gastrointestinal side effects.

Suitable Patient Groups:

The medication is suitable for adults, including the elderly, and children above a certain age as determined by a healthcare provider.

Storage and Shelf Life:

Store Glencet Edvans Coated Tablets №28 in a cool, dry place. Check the expiration date on the packaging and do not use the tablets beyond this date.

Packaging Description:

The tablets are packaged in a blister pack containing 28 coated tablets.

Clinical Evidence and Proven Effectiveness:

Studies have shown that the active ingredient in Glencet Edvans Coated Tablets №28 is effective in reducing symptoms of condition A. Research published in the Journal of Clinical Research demonstrated a significant improvement in patients who took this medication compared to placebo.